Early mortality and survival improvements for adolescents and young adults with acute promyelocytic leukemia in California: an updated analysis.
作者信息
Abrahão Renata, Ribeiro Raul C, Malogolowkin Marcio H, Wun Ted, Keegan Theresa H M
机构信息
Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, University of California Comprehensive Cancer Center, Sacramento-CA, USA; Center for Healthcare Policy and Research, University of California, Davis, School of Medicine, Sacramento-CA.
Department of Oncology, Division of Hematology and Oncology, St. Jude Children's Research Hospital, Memphis-TN.
出版信息
Haematologica. 2022 Mar 1;107(3):733-736. doi: 10.3324/haematol.2021.278851.
Abstract
摘要
相似文献
1
Early mortality and survival improvements for adolescents and young adults with acute promyelocytic leukemia in California: an updated analysis.加利福尼亚州青少年和青年急性早幼粒细胞白血病患者的早期死亡率及生存改善情况：一项更新分析
Haematologica. 2022 Mar 1;107(3):733-736. doi: 10.3324/haematol.2021.278851.
2
Early death in acute promyelocytic leukemia (APL) in French centers: a multicenter study in 399 patients.法国各中心急性早幼粒细胞白血病（APL）患者的早期死亡情况：一项针对399例患者的多中心研究。
Leukemia. 2014 Dec;28(12):2422-4. doi: 10.1038/leu.2014.240. Epub 2014 Aug 21.
3
Diagnosis and incidence of acute promyelocytic leukemia (FAB M3 and M3 variant) in childhood.儿童急性早幼粒细胞白血病（FAB M3及M3变异型）的诊断与发病率
Blood. 1993 Apr 15;81(8):2209-10.
4
High frequency of acute promyelocytic leukemia in northwest Iran.伊朗西北部急性早幼粒细胞白血病的高发病率。
Asian Pac J Cancer Prev. 2004 Apr-Jun;5(2):188-9.
5
Outcome of relapsed/refractory acute promyelocytic leukaemia in children, adolescents and young adult patients - a 25-year Italian experience.儿童、青少年和年轻成年患者复发/难治性急性早幼粒细胞白血病的治疗结果——一项为期25年的意大利经验。
Br J Haematol. 2021 Oct;195(2):278-283. doi: 10.1111/bjh.17637. Epub 2021 Jun 17.
6
Complications and early mortality in patients with acute promyelocytic leukemia treated in California.加利福尼亚州急性早幼粒细胞白血病患者的并发症与早期死亡率
Am J Hematol. 2018 Nov;93(11):E370-E372. doi: 10.1002/ajh.25252. Epub 2018 Sep 26.
7
Addressing the room for improvement in management of acute promyelocytic leukemia.探讨急性早幼粒细胞白血病管理的改进空间。
Eur J Haematol. 2019 Jun;102(6):479-485. doi: 10.1111/ejh.13229. Epub 2019 Apr 7.
8
Treatment advances have not improved the early death rate in acute promyelocytic leukemia.治疗进展并未改善急性早幼粒细胞白血病的早期死亡率。
Haematologica. 2012 Jan;97(1):133-6. doi: 10.3324/haematol.2011.046490. Epub 2011 Oct 11.
9
Impact of sociodemographic factors on early mortality in acute promyelocytic leukemia in the United States: A time-trend analysis.社会人口因素对美国急性早幼粒细胞白血病早期死亡率的影响：时间趋势分析。
Cancer. 2022 Jan 15;128(2):292-298. doi: 10.1002/cncr.33914. Epub 2021 Sep 8.
10
A highly unusual cluster of acute promyelocytic leukaemia: an environmental aetiology?急性早幼粒细胞白血病的一个极为罕见的聚集病例：环境病因？
Clin Lab Haematol. 2005 Feb;27(1):71-3. doi: 10.1111/j.1365-2257.2004.00663.x.
引用本文的文献
1
Stage at diagnosis and survival among adolescents and young adults with lymphomas following the Affordable Care Act implementation in California.加州平价医疗法案实施后青少年和青年淋巴瘤患者的诊断时分期和生存情况。
Int J Cancer. 2022 Apr 1;150(7):1113-1122. doi: 10.1002/ijc.33880. Epub 2021 Dec 8.
2
Timely diagnosis and treatment of acute promyelocytic leukemia should be available to all.应让所有人都能获得急性早幼粒细胞白血病的及时诊断和治疗。
Haematologica. 2022 Mar 1;107(3):570-571. doi: 10.3324/haematol.2021.279052.
本文引用的文献
1
The Affordable Care Act and access to care across the cancer control continuum: A review at 10 years.平价医疗法案与癌症防治连续体中的医疗服务可及性：10 年回顾。
CA Cancer J Clin. 2020 May;70(3):165-181. doi: 10.3322/caac.21604. Epub 2020 Mar 23.
2
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial.全反式维甲酸和三氧化二砷治疗非高危急性早幼粒细胞白血病的长期结果：APL0406意大利-德国随机试验的更新
Leukemia. 2020 Mar;34(3):914-918. doi: 10.1038/s41375-019-0589-3. Epub 2019 Oct 14.
3
Complications and early mortality in patients with acute promyelocytic leukemia treated in California.加利福尼亚州急性早幼粒细胞白血病患者的并发症与早期死亡率
Am J Hematol. 2018 Nov;93(11):E370-E372. doi: 10.1002/ajh.25252. Epub 2018 Sep 26.
4
Progress and criticalities in the management of acute promyelocytic leukemia.急性早幼粒细胞白血病治疗的进展与关键问题
Oncotarget. 2017 Nov 12;8(59):99221-99222. doi: 10.18632/oncotarget.22385. eCollection 2017 Nov 21.
5
Early death rates remain high in high-risk APL: update from the Swedish Acute Leukemia Registry 1997-2013.高危急性早幼粒细胞白血病的早期死亡率仍然很高：瑞典急性白血病登记处1997 - 2013年的更新数据
Leukemia. 2017 Jun;31(6):1457-1459. doi: 10.1038/leu.2017.71. Epub 2017 Feb 24.
6
Targeted Therapy Alone for Acute Promyelocytic Leukemia.急性早幼粒细胞白血病的单纯靶向治疗
N Engl J Med. 2016 Mar 24;374(12):1197-8. doi: 10.1056/NEJMc1513710.
7
Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.三氧化二砷和全反式维甲酸治疗所有风险组急性早幼粒细胞白血病（AML17）：一项随机、对照、3 期临床试验的结果。
Lancet Oncol. 2015 Oct;16(13):1295-305. doi: 10.1016/S1470-2045(15)00193-X. Epub 2015 Sep 14.
8
Disparities in early death and survival in children, adolescents, and young adults with acute promyelocytic leukemia in California.加利福尼亚州急性早幼粒细胞白血病儿童、青少年及年轻成年人的早期死亡和生存差异。
Cancer. 2015 Nov 15;121(22):3990-7. doi: 10.1002/cncr.29631. Epub 2015 Aug 11.
9
Impact of hospital volume on outcomes of patients undergoing chemotherapy for acute myeloid leukemia: a matched cohort study.医院规模对急性髓系白血病化疗患者结局的影响：一项匹配队列研究。
Blood. 2015 May 21;125(21):3359-60. doi: 10.1182/blood-2015-01-625764.
10
Limitations in health care access and utilization among long-term survivors of adolescent and young adult cancer.青少年和年轻成人癌症长期幸存者的医疗保健可及性和利用方面的局限性。
Cancer. 2012 Dec 1;118(23):5964-72. doi: 10.1002/cncr.27537. Epub 2012 Sep 24.
Zotero 插件